Report Detail
Global Propofol Injection for Operation General Anesthesia Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4743789 |
- 28 September, 2026 |
- Global |
- 120 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Propofol Injection for Operation General Anesthesia market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Propofol injection is used as an adjunct to spinal and epidural anesthesia, and it is used in conjunction with commonly used preoperative medications, neuromuscular blocking agents, inhaled anesthetics and analgesics, and no drug incompatibility has been encountered. It is used as a general anesthesia to complement regional anesthesia techniques, requiring lower doses. And often supplemental pain medication is required.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Propofol Injection for Operation General Anesthesia market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Specification and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Propofol Injection for Operation General Anesthesia market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Propofol Injection for Operation General Anesthesia market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Propofol Injection for Operation General Anesthesia market size and forecasts, by Specification and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Propofol Injection for Operation General Anesthesia market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Propofol Injection for Operation General Anesthesia
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Propofol Injection for Operation General Anesthesia market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, AstraZeneca, Nhwa, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Propofol Injection for Operation General Anesthesia market is split by Specification and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Specification, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Specification
10ml
20ml
50ml
Others
Market segment by Application
Hopitals
Clinics
Others
Major players covered
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xi'an Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Propofol Injection for Operation General Anesthesia product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Propofol Injection for Operation General Anesthesia, with price, sales quantity, revenue, and global market share of Propofol Injection for Operation General Anesthesia from 2021 to 2026.
Chapter 3, the Propofol Injection for Operation General Anesthesia competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Propofol Injection for Operation General Anesthesia breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Specification and by Application, with sales market share and growth rate by Specification, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Propofol Injection for Operation General Anesthesia market forecast, by regions, by Specification, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Propofol Injection for Operation General Anesthesia.
Chapter 14 and 15, to describe Propofol Injection for Operation General Anesthesia sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Specification
- 1.3.1 Overview: Global Propofol Injection for Operation General Anesthesia Consumption Value by Specification: 2021 Versus 2025 Versus 2032
- 1.3.2 10ml
- 1.3.3 20ml
- 1.3.4 50ml
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Propofol Injection for Operation General Anesthesia Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hopitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Global Propofol Injection for Operation General Anesthesia Market Size & Forecast
- 1.5.1 Global Propofol Injection for Operation General Anesthesia Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Propofol Injection for Operation General Anesthesia Sales Quantity (2021-2032)
- 1.5.3 Global Propofol Injection for Operation General Anesthesia Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Aspen Pharma
- 2.1.1 Aspen Pharma Details
- 2.1.2 Aspen Pharma Major Business
- 2.1.3 Aspen Pharma Propofol Injection for Operation General Anesthesia Product and Services
- 2.1.4 Aspen Pharma Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Aspen Pharma Recent Developments/Updates
- 2.2 Fresenius-Kabi
- 2.2.1 Fresenius-Kabi Details
- 2.2.2 Fresenius-Kabi Major Business
- 2.2.3 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product and Services
- 2.2.4 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Fresenius-Kabi Recent Developments/Updates
- 2.3 AbbVie
- 2.3.1 AbbVie Details
- 2.3.2 AbbVie Major Business
- 2.3.3 AbbVie Propofol Injection for Operation General Anesthesia Product and Services
- 2.3.4 AbbVie Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 AbbVie Recent Developments/Updates
- 2.4 Baxter Healthcare
- 2.4.1 Baxter Healthcare Details
- 2.4.2 Baxter Healthcare Major Business
- 2.4.3 Baxter Healthcare Propofol Injection for Operation General Anesthesia Product and Services
- 2.4.4 Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Baxter Healthcare Recent Developments/Updates
- 2.5 B.Braun
- 2.5.1 B.Braun Details
- 2.5.2 B.Braun Major Business
- 2.5.3 B.Braun Propofol Injection for Operation General Anesthesia Product and Services
- 2.5.4 B.Braun Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 B.Braun Recent Developments/Updates
- 2.6 Maruishi
- 2.6.1 Maruishi Details
- 2.6.2 Maruishi Major Business
- 2.6.3 Maruishi Propofol Injection for Operation General Anesthesia Product and Services
- 2.6.4 Maruishi Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Maruishi Recent Developments/Updates
- 2.7 Piramal
- 2.7.1 Piramal Details
- 2.7.2 Piramal Major Business
- 2.7.3 Piramal Propofol Injection for Operation General Anesthesia Product and Services
- 2.7.4 Piramal Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Piramal Recent Developments/Updates
- 2.8 Hikma Pharmaceuticals
- 2.8.1 Hikma Pharmaceuticals Details
- 2.8.2 Hikma Pharmaceuticals Major Business
- 2.8.3 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product and Services
- 2.8.4 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
- 2.9 AstraZeneca
- 2.9.1 AstraZeneca Details
- 2.9.2 AstraZeneca Major Business
- 2.9.3 AstraZeneca Propofol Injection for Operation General Anesthesia Product and Services
- 2.9.4 AstraZeneca Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 AstraZeneca Recent Developments/Updates
- 2.10 Nhwa
- 2.10.1 Nhwa Details
- 2.10.2 Nhwa Major Business
- 2.10.3 Nhwa Propofol Injection for Operation General Anesthesia Product and Services
- 2.10.4 Nhwa Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Nhwa Recent Developments/Updates
- 2.11 Hengrui
- 2.11.1 Hengrui Details
- 2.11.2 Hengrui Major Business
- 2.11.3 Hengrui Propofol Injection for Operation General Anesthesia Product and Services
- 2.11.4 Hengrui Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Hengrui Recent Developments/Updates
- 2.12 Xi'an Libang
- 2.12.1 Xi'an Libang Details
- 2.12.2 Xi'an Libang Major Business
- 2.12.3 Xi'an Libang Propofol Injection for Operation General Anesthesia Product and Services
- 2.12.4 Xi'an Libang Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Xi'an Libang Recent Developments/Updates
- 2.13 Yichang Humanwell
- 2.13.1 Yichang Humanwell Details
- 2.13.2 Yichang Humanwell Major Business
- 2.13.3 Yichang Humanwell Propofol Injection for Operation General Anesthesia Product and Services
- 2.13.4 Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Yichang Humanwell Recent Developments/Updates
- 2.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
- 2.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Details
- 2.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Major Business
- 2.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product and Services
- 2.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
3 Competitive Environment: Propofol Injection for Operation General Anesthesia by Manufacturer
- 3.1 Global Propofol Injection for Operation General Anesthesia Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturer (2021-2026)
- 3.3 Global Propofol Injection for Operation General Anesthesia Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Propofol Injection for Operation General Anesthesia by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Propofol Injection for Operation General Anesthesia Manufacturer Market Share in 2025
- 3.4.3 Top 6 Propofol Injection for Operation General Anesthesia Manufacturer Market Share in 2025
- 3.5 Propofol Injection for Operation General Anesthesia Market: Overall Company Footprint Analysis
- 3.5.1 Propofol Injection for Operation General Anesthesia Market: Region Footprint
- 3.5.2 Propofol Injection for Operation General Anesthesia Market: Company Product Type Footprint
- 3.5.3 Propofol Injection for Operation General Anesthesia Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Propofol Injection for Operation General Anesthesia Market Size by Region
- 4.1.1 Global Propofol Injection for Operation General Anesthesia Sales Quantity by Region (2021-2032)
- 4.1.2 Global Propofol Injection for Operation General Anesthesia Consumption Value by Region (2021-2032)
- 4.1.3 Global Propofol Injection for Operation General Anesthesia Average Price by Region (2021-2032)
- 4.2 North America Propofol Injection for Operation General Anesthesia Consumption Value (2021-2032)
- 4.3 Europe Propofol Injection for Operation General Anesthesia Consumption Value (2021-2032)
- 4.4 Asia-Pacific Propofol Injection for Operation General Anesthesia Consumption Value (2021-2032)
- 4.5 South America Propofol Injection for Operation General Anesthesia Consumption Value (2021-2032)
- 4.6 Middle East & Africa Propofol Injection for Operation General Anesthesia Consumption Value (2021-2032)
5 Market Segment by Specification
- 5.1 Global Propofol Injection for Operation General Anesthesia Sales Quantity by Specification (2021-2032)
- 5.2 Global Propofol Injection for Operation General Anesthesia Consumption Value by Specification (2021-2032)
- 5.3 Global Propofol Injection for Operation General Anesthesia Average Price by Specification (2021-2032)
6 Market Segment by Application
- 6.1 Global Propofol Injection for Operation General Anesthesia Sales Quantity by Application (2021-2032)
- 6.2 Global Propofol Injection for Operation General Anesthesia Consumption Value by Application (2021-2032)
- 6.3 Global Propofol Injection for Operation General Anesthesia Average Price by Application (2021-2032)
7 North America
- 7.1 North America Propofol Injection for Operation General Anesthesia Sales Quantity by Specification (2021-2032)
- 7.2 North America Propofol Injection for Operation General Anesthesia Sales Quantity by Application (2021-2032)
- 7.3 North America Propofol Injection for Operation General Anesthesia Market Size by Country
- 7.3.1 North America Propofol Injection for Operation General Anesthesia Sales Quantity by Country (2021-2032)
- 7.3.2 North America Propofol Injection for Operation General Anesthesia Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Propofol Injection for Operation General Anesthesia Sales Quantity by Specification (2021-2032)
- 8.2 Europe Propofol Injection for Operation General Anesthesia Sales Quantity by Application (2021-2032)
- 8.3 Europe Propofol Injection for Operation General Anesthesia Market Size by Country
- 8.3.1 Europe Propofol Injection for Operation General Anesthesia Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Propofol Injection for Operation General Anesthesia Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Quantity by Specification (2021-2032)
- 9.2 Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Propofol Injection for Operation General Anesthesia Market Size by Region
- 9.3.1 Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Propofol Injection for Operation General Anesthesia Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Propofol Injection for Operation General Anesthesia Sales Quantity by Specification (2021-2032)
- 10.2 South America Propofol Injection for Operation General Anesthesia Sales Quantity by Application (2021-2032)
- 10.3 South America Propofol Injection for Operation General Anesthesia Market Size by Country
- 10.3.1 South America Propofol Injection for Operation General Anesthesia Sales Quantity by Country (2021-2032)
- 10.3.2 South America Propofol Injection for Operation General Anesthesia Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Quantity by Specification (2021-2032)
- 11.2 Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Propofol Injection for Operation General Anesthesia Market Size by Country
- 11.3.1 Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Propofol Injection for Operation General Anesthesia Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Propofol Injection for Operation General Anesthesia Market Drivers
- 12.2 Propofol Injection for Operation General Anesthesia Market Restraints
- 12.3 Propofol Injection for Operation General Anesthesia Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Propofol Injection for Operation General Anesthesia and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Propofol Injection for Operation General Anesthesia
- 13.3 Propofol Injection for Operation General Anesthesia Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Propofol Injection for Operation General Anesthesia Typical Distributors
- 14.3 Propofol Injection for Operation General Anesthesia Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Propofol Injection for Operation General Anesthesia. Industry analysis & Market Report on Propofol Injection for Operation General Anesthesia is a syndicated market report, published as Global Propofol Injection for Operation General Anesthesia Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Propofol Injection for Operation General Anesthesia market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
